Optimal Dose of Anti-lymphocyte Globulin in Kidney Transplant Recipients With Low Immunological Risk
Clinical trial NCT06744400 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06744400
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2026-01-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.